Pinnacle Associates’s CollPlant Biotechnologies CLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Sell
550,229
-6,964
-1% -$7.03K ﹤0.01% 807
2025
Q4
$780K Buy
557,193
+50,000
+10% +$102K 0.01% 566
2025
Q3
$1.36M Hold
507,193
0.02% 458
2025
Q2
$690K Buy
507,193
+18,000
+4% +$37.3K 0.01% 570
2025
Q1
$1.26M Sell
489,193
-500
-0.1% -$1.76K 0.02% 453
2024
Q4
$1.76M Buy
489,693
+21,584
+5% +$87.8K 0.02% 390
2024
Q3
$2.99M Sell
468,109
-96,251
-17% -$471K 0.05% 297
2024
Q2
$2.8M Buy
564,360
+33,905
+6% +$188K 0.04% 314
2024
Q1
$2.84M Buy
530,455
+62,346
+13% +$337K 0.04% 321
2023
Q4
$2.99M Sell
468,109
-10,200
-2% -$55.8K 0.05% 300
2023
Q3
$2.66M Sell
478,309
-6,344
-1% -$42K 0.05% 311
2023
Q2
$3.95M Buy
+484,653
New +$3.53M 0.07% 258

Other funds holding CLGN